Now that Asterias Biotherapeutics’ CIRM-funded, stem cell-based clinical trial for spinal cord injury (SCI) has safely treated its first group of patients and begun recruiting the second, should other SCI researchers close up shop? Of course not. Since it’s a first-in-human trial, there certainly will be room for improvement even if the therapy proves successful. … Continue reading Researchers Identify Potential New Cell Source for Spinal Cord Injury Treatments